Chemical formula: C₅H₁₀N₂O₇P₂ Molecular mass: 272.09 g/mol PubChem compound: 68740
Zoledronic acid belongs to the class of bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclastic bone resorption.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M05BA08 | Zoledronic acid | M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| ZOLEDRONIC ACID HOSPIRA 4mg/100ml Solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ZOLEDRONIC ACID HOSPIRA 5mg/100ml Solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
Zoledronic acid is an active ingredient of these brands:
Brazil (BR)Ecuador (EC)Estonia (EE)Finland (FI)Germany (DE)
Israel (IL)Lithuania (LT)Nigeria (NG)Singapore (SG)South Africa (ZA)
Turkey (TR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
